Get started
Author

Enrica Borsi

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
2015 · Elena Zamagni, Cristina Nanni, et al. · Clinical Cancer Research · 176
Italian cancer figures, report 2012: Cancer in children and adolescents.
2013 · Paola Pisani, Carlotta Buzzoni, et al. · BOA (University of Milano-Bicocca) · 117
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
2014 · Enrica Borsi, Carolina Terragna, et al. · Translational research · 59
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma
2014 · Enrica Borsi, Giulia Perrone, et al. · Oncotarget · 57
PDF
Bortezomib‐based therapy combined with high cut‐off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment
2015 · Beatrice Anna Zannetti, Elena Zamagni, et al. · American Journal of Hematology · 42
PDF
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma
2022 · M. Martello, A. Poletti, et al. · Blood Cancer Journal · 40
PDF
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)
2015 · Carolina Terragna, Daniel Remondini, et al. · Oncotarget · 32
PDF
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment
2014 · Enrica Borsi, Giulia Perrone, et al. · Experimental Cell Research · 30
Cytoplasmatic compartmentalization by Bcr‐Abl promotes TET2 loss‐of‐function in chronic myeloid leukemia
2012 · Manuela Mancini, Nevena Veljkovic, et al. · Journal of Cellular Biochemistry · 22
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis
2009 · Annalisa Pezzi, Luca Roncucci, et al. · Scandinavian Journal of Gastroenterology · 21
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis
2024 · Marina Martello, Vincenza Solli, et al. · Blood Cancer Journal · 20
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens
2016 · Paola Tacchetti, Michele Cavo, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 20
Analysis of mismatch repair gene mutations in Turkish HNPCC patients
2010 · Berrin Tunca, Monica Pedroni, et al. · Familial Cancer · 18
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells
2013 · Manuela Mancini, Elisa Leo, et al. · Cellular Signalling · 17
PDF
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma
2021 · Anna Russignan, Giada Dal Collo, et al. · Frontiers in Oncology · 15
PDF
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
2022 · Ilaria Vigliotta, Silvia Armuzzi, et al. · Frontiers in Oncology · 13
PDF
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138−CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis
2016 · M Martello, D Remondini, et al. · Leukemia · 13
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
2024 · Carolina Terragna, Andrea Poletti, et al. · Nature Communications · 12
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor
2012 · Manuela Mancini, Elisa Leo, et al. · Leukemia Research · 12
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
2024 · Enrica Borsi, Ilaria Vigliotta, et al. · Cells · 11
PDF
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
2023 · Katia Mancuso, Elena Zamagni, et al. · Frontiers in Oncology · 10
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients
2024 · Ilaria Vigliotta, Vincenza Solli, et al. · Cancers · 8
PDF
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets
2024 · Samantha Bruno, Enrica Borsi, et al. · International Journal of Molecular Sciences · 5
PDF
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients
2023 · Enrica Borsi, Gaia Mazzocchetti, et al. · Clinical and Experimental Medicine · 5
PDF
BoBafit : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles
2022 · G. Mazzocchetti, A. Poletti, et al. · Computational and Structural Biotechnology Journal · 4
Works count: 111
Citation count: 806
H-index: 15
I10-index: 21
Year
Topic
Type